With multiple medicine use on the rise, a UK study has set out to gather evidence for safer practices to get patients off the drugs they no longer need.

Patients with multiple medical conditions – and, consequently, needing multiple medications – present one of the greatest challenges currently facing health services.

When it comes to pharmacovigilance in older patients, age alone is insufficient as a measure of adverse reaction risk. Here is what we should consider instead.

Medication errors are a key pharmacovigilance issue, especially as patients transition between secondary and primary care as they readjust to life outside of hospital.

Compared to the general population, older adults are more at risk of experiencing adverse drug reactions. Why is this the case, and what does this mean for pharmacovigilance?